Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687656 · ClinicalTrials.gov registry record · NA
Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer, sponsored by ConvaTec.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 5
- Study locations
NCT05687656: Active NA study of Diabetic Foot Ulcer, sponsored by ConvaTec.
NCT05687656 is a NA study of Diabetic Foot Ulcer that is active but no longer recruiting, run by ConvaTec. The registered enrollment target is 30 participants, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (88% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05687656, a NA study of Diabetic Foot Ulcer, is active but no longer recruiting, sponsored by ConvaTec.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 5
- Study locations
Study Summary
A Prospective, Non-Randomized, Multi-Center Observational Study To determine the safety and effectiveness of InnovaMatrix AC porcine placental ECM therapy for the treatment of chronic, non-healing diabetic foot ulcers (DFUs) Eligible subjects will be treated with a weekly application of sterilized, porcine placental ECM followed by standard of care wound therapy and offloading
Primary Outcome
The primary endpoint for the study is assessment of ulcer area at Weeks 6 and 12 using the MolecuLight Imaging Device
Conditions Studied
Interventions
- DEVICE InnovaMatrix AC porcine placental ECM therapy
Study Locations (5)
Texas
- SerenaGroup Austin Research Center - Austin
- Atrium Medical Center - Stafford
Florida
- Three Rivers Hyperbaric and Wound Center - North Port
New York
- Serena Group Buffalo Research Center - Buffalo
Pennsylvania
- SerenaGroup Monroeville - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT05687656 still lists
NCT05687656 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which InnovaMatrix AC porcine placental ECM therapy is the first listed.
NCT05687656 lists 5 locations in 4 states (Texas, Florida, New York).
Frequently Asked Questions
What is clinical trial NCT05687656 about?
NCT05687656 is a clinical study titled "Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers". A Prospective, Non-Randomized, Multi-Center Observational Study To determine the safety and effectiveness of InnovaMatrix AC porcine placental ECM therapy for the treatment of chronic, non-healing diabetic foot ulcers (DFUs) Eligible subjects will be treated with a weekly application of sterilized...
What is the current status of trial NCT05687656?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-10-06. Estimated completion is 2025-12-31.
What conditions does trial NCT05687656 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT05687656?
The interventions under investigation include: InnovaMatrix AC porcine placental ECM therapy (DEVICE).
Who is sponsoring clinical trial NCT05687656?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05687656 being conducted?
This trial has 5 study locations across Florida, New York, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05687656's enrollment target sits among peer trials
30 55th of 67 higher than 12 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI